Acute myocardial infarction
Acute myocardial infarction (AMI) refers to acute necrosis of part of the myocardium due to persistent and severe myocardial ischemia. Clinically, it is often manifested as chest pain, acute circulatory dysfunction, and a series of characteristic electrocardiogram changes reflecting myocardial damage, ischemia, and necrosis. Clinical manifestations often include persistent severe pain behind the sternum, acute circulatory dysfunction, arrhythmia, heart failure, fever, elevated white blood cell count and serum myocardial injury marker enzymes, and progressive electrocardiogram changes of acute myocardial damage and necrosis. According to the scope of infarction, myocardial infarction can be divided into two categories: transmural myocardial infarction and subendocardial myocardial infarction. According to the development process of the lesion, myocardial infarction can be divided into acute myocardial infarction and old myocardial infarction.
-
Site of disease:
Heart blood vessels -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Chest pain cardiopulmonary embolism extensive myocardial necrosis upper abdominal pain chest tightness and breathlessness -
Concurrent disease:
Related Drugs
Lidocaine Hydrochloride Injection (Solvent)
Indication: This product is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. This product can also be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and can also be used for ventricular arrhythmias caused by digitalis poisoning, cardiac surgery and cardiac catheterization. This product is usually ineffective for supraventricular arrhythmias.
Manufacturer:
Shandong Shenglu Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Injection (Solvent)
Indication: This product is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. This product can also be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and can also be used for ventricular arrhythmias caused by digitalis poisoning, cardiac surgery and cardiac catheterization. This product is usually ineffective for supraventricular arrhythmias.
Manufacturer:
Fuzhou Jiji Pharmaceutical Technology Co., Ltd.
Lidocaine Hydrochloride Injection (Solvent)
Indication: This product is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. This product can also be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and can also be used for ventricular arrhythmias caused by digitalis poisoning, cardiac surgery and cardiac catheterization. This product is usually ineffective for supraventricular arrhythmias.
Manufacturer:
Shiyao YINHU Pharmaceutical Co., Ltd.
Sodium fructose diphosphate
Indication: It is suitable for improving angina pectoris, acute myocardial infarction and arrhythmia caused by coronary heart disease, and myocardial ischemia caused by heart failure.
Manufacturer:
Hebei Changtian Pharmaceutical Co., Ltd.
Metoprolol tartrate controlled release tablets
Indication: Hypertension, angina pectoris, etc.
Manufacturer:
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Norepinephrine bitartrate injection
Indication: Used to treat hypotension caused by acute myocardial infarction, extracorporeal circulation, etc.; for shock, hypotension or hypotension after pheochromocytoma resection caused by insufficient blood volume, this product is used as an auxiliary treatment to supplement blood volume during emergency treatment to restore blood pressure and temporarily maintain brain and coronary artery perfusion until the blood volume supplementation treatment takes effect; it can also be used for hypotension during intrathecal blockade and blood pressure maintenance after cardiac arrest resuscitation.
Manufacturer:
GRAND PHARMACEUTICAL(China) Co., Ltd.
Metoprolol Tartrate Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Metoprolol Tartrate Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Manufacturer:
Hubei Jinyao Pharmaceutical Co., Ltd.
Metoprolol Tartrate Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Metoprolol Tartrate Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Manufacturer:
CSPC OUYI Pharmaceutical Co., Ltd.